News

GHTC
GHTC issues statement on antimicrobial resistance at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session welcoming the World Health Organization’s (WHO) efforts to combat antimicrobial drug resistance (AMR). The statement, issues with PATH, calls on the US government to support these efforts, with a focus on prioritizing development of a range of new tools, as well as to support the establishment of the Global Antimicrobial Surveillance System.

PDF

GHTC
GHTC issues statement on R&D for epidemic diseases at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session highlighting the critical role new tools play in epidemic preparedness. The statement, issued with PATH, calls on the US government to support regulatory capacity building and harmonization efforts with the World Health Organization and efforts by the Coalition for Epidemic Preparedness, as well as notes the necessity of developing affordable and available tools in order to combat potentially epidemic diseases in low-resource settings, where outbreaks most often occur.

PDF

GHTC
GHTC issues statement on WHO R&D observatory, pooled fund at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session supporting the rapid establishment and full funding for the World Health Organization (WHO) Global Observatory on Health Research and Development, as well as ongoing efforts to establish a pooled fund. The statement, issued with PATH, also calls for transparency to ensure the fund’s foundation is sound science and public health.

PDF

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide